Cerus Corp Share Price Today: Live Updates & Key Insights

Cerus Corp share price today is $1.71, up -2.27%. The stock opened at $1.75 against the previous close of $1.76, with an intraday high of $1.76 and low of $1.68.

Cerus Corp Share Price Chart

Cerus Corp

us-stock
To Invest in {{usstockname}}
us-stock

Cerus Corp Share Price Performance

$1.71 -0.0227(-2.27%) CERS at 23 Mar 2026 12:25 PM Medical Devices
Lowest Today 1.68
Highest Today 1.76
Today’s Open 1.75
Prev. Close 1.76
52 Week High 2.96
52 Week Low 1.12
Day’s Range: Low 1.68 High 1.76
52-Week Range: Low 1.12 High 2.96
1 day return -
1 Week return -4.98
1 month return -28.24
3 month return -18.72
6 month return +13.57
1 year return +9.93
3 year return -38.96
5 year return -72.38
10 year return -

Cerus Corp Institutional Holdings

BlackRock Inc 10.92

ARK Investment Management LLC 9.47

Vanguard Group Inc 5.81

Baker Bros Advisors LP 5.21

ARK Disruptive Innovation Full Composite 5.04

ARK Innovation ETF 4.94

ARK Genomic Revolution ETF 3.44

ARK Genomic Revolution 3.34

Vanguard Total Stock Mkt Idx Inv 2.98

Sumitomo Mitsui Trust Group Inc 2.96

Wasatch Advisors LP 2.84

Wasatch Ultra Growth 2.79

Amova Asset Management Americas, Inc 2.45

Silvercrest Asset Management Group LLC 2.44

Geode Capital Management, LLC 2.34

iShares Russell 2000 ETF 2.32

Amova ARK Disruptive Innovation A USD 2.08

RIMA MANAGEMENT, LLC 2.06

D. E. Shaw & Co LP 2.02

State Street Corp 2.01

Acadian Asset Management LLC 1.50

SILVERARC CAPITAL MANAGEMENT, LLC 1.46

The Goldman Sachs Group Inc 1.27

IEQ CAPITAL, LLC 1.26

Vanguard Institutional Extnd Mkt Idx Tr 1.09

AQR Capital Management LLC 1.04

Two Sigma Investments LLC 0.97

Fidelity Small Cap Index 0.95

Morgan Stanley - Brokerage Accounts 0.94

Assenagon Asset Management SA 0.87

BlackRock Advantage Small Cap Core Instl 0.80

iShares Russell 2000 Growth ETF 0.79

Silvercrest U.S. Small Cap Growth 0.68

State St Russell Sm/Mid Cp® Indx SL Cl I 0.56

Fidelity Extended Market Index 0.53

Fidelity Enhanced Small Cap ETF 0.50

Schwab US Small-Cap ETF™ 0.49

Vanguard Russell 2000 ETF 0.46

iShares U.S. Small-Cap Eq Fac ETF 0.45

BlackRock Advantage Small Cap Gr Instl 0.44

Cerus Corp Market Status

Strong Buy: 4

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

Cerus Corp Fundamentals

Market Cap 330.54 M

PB Ratio 5.1466

PE Ratio 0.0

Enterprise Value 344.60 M

Total Assets 221.86 M

Volume 2055952

Cerus Corp Company Financials

Annual Revenue FY24:180270000 180.3M, FY23:153633000 153.6M, FY22:162048000 162.0M, FY21:130859000 130.9M, FY20:91920000 91.9M

Annual Profit FY24:99522000 99.5M, FY23:84977000 85.0M, FY22:87094000 87.1M, FY21:67384000 67.4M, FY20:50763000 50.8M

Annual Net worth FY24:-20918000 -20.9M, FY23:-49785000 -49.8M, FY22:-42825000 -42.8M, FY21:-54376000 -54.4M, FY20:-59857000 -59.9M

Quarterly Revenue Q3/2025:52698000 52.7M, Q2/2025:52445000 52.4M, Q1/2025:43239000 43.2M, Q4/2024:50809000 50.8M, Q3/2024:46017000 46.0M

Quarterly Profit Q3/2025:28140000 28.1M, Q2/2025:28975000 29.0M, Q1/2025:25424000 25.4M, Q4/2024:27385000 27.4M, Q3/2024:26199000 26.2M

Quarterly Net worth Q3/2025:-19000 -0.0M, Q2/2025:-5707000 -5.7M, Q1/2025:-7717000 -7.7M, Q4/2024:-2521000 -2.5M, Q3/2024:-2934000 -2.9M

About Cerus Corp & investment objective

Company Information Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company also offers INTERCEPT Blood Systems for platelets plasma, and cryoprecipitation, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells intended for transfusion; INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma and cryoprecipitate reduced; and INTERCEPT Illuminator, an LED-based device for blood component treatment. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was formerly known as CERUS TECHNOLOGIES INC and changed its name to Cerus Corporation in July 1996. The company was incorporated in 1991 and is headquartered in Concord, California.

Organisation Medical Devices

Employees 261

Industry Medical Devices

CEO Mr. William M. Greenman

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Cerus Corp FAQs

What is the share price of Cerus Corp today?

The current share price of Cerus Corp is $1.71.

Can I buy Cerus Corp shares in India?

Yes, Indian investors can buy Cerus Corp shares by opening an international trading and demat account with Motilal Oswal.

How to buy Cerus Corp shares in India?

You can easily invest in Cerus Corp shares from India by:

Can I buy fractional shares of Cerus Corp?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Cerus Corp?

Cerus Corp has a market cap of $330.54 M.

In which sector does Cerus Corp belong?

Cerus Corp operates in the Medical Devices sector.

What documents are required to invest in Cerus Corp stocks?

To invest, you typically need:

What is the PE and PB ratio of Cerus Corp?

The PE ratio of Cerus Corp is N/A and the PB ratio is 5.15.